Confirmation Received from MHLW That QRX003 Qualifies for Both Orphan Drug Designation and Fast Track Regulatory Review Status Quoin Initiating the Establishment of a Japanese Subsidiary to Facilitate Self-Commercialization of QRX003 in Japan, if Approved Orphan Drug Designation Previously Granted by Both the U.S. Food and Drug Administration (FDA) and… Read More..

Investment Brings a Total of $14 Million to SKYX in Recent Funding Over the Past 3 Months from Strategic Investors and Long-Term Shareholders as SKYX continues its Market Penetration and Path to Cash Flow Positive MIAMI, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies)… Read More..

 NVIDIA Connect Supports Advanced Technology Companies Developing AI-powered Products Part of NVIDIA’s Connect Program is to Promote, Assist, and Identify Go-To-Market Opportunities SKYX Expects to Include its All-In-One Smart Platform and Hub, in Collaboration with NVIDIA’s AI Features, in Future U.S. and Global Projects, Including the Upcoming $4 Billion Miami,… Read More..